Home › Funds › Renaissance Technologies › ESPR
Renaissance Technologies position in ESPR
ESPERION THERAPEUTICS INC NE
Latest position (Q2 2026)160.20K sh
Reported value held$506.23K
Portfolio Weight0.00%
First reportedQ1 2022
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2022 | 422.20K | $1.96M | New |
| Q2 2022 | 385.30K | $2.45M | Reduce |
| Q3 2022 | 286.70K | $1.92M | Reduce |
| Q2 2023 | 114.30K | $159 | New |
| Q3 2023 | 206.16K | $202 | Add |
| Q4 2023 | 1.42M | $4.25K | Add |
| Q1 2024 | 2.12M | $5.67K | Add |
| Q2 2024 | 1.42M | $3.16M | Reduce |
| Q3 2024 | 914.10K | $1.51M | Reduce |
| Q4 2024 | 578.80K | $1.27M | Reduce |
| Q2 2025 | 292.40K | $287.84K | New |
| Q2 2025 | 292.40K | $287.84K | New |
| Q3 2025 | 773.90K | $2.05M | Add |
| Q4 2025 | 2.19M | $8.12M | Add |
| Q1 2026 | 1.62M | $4.44M | Reduce |
| Q2 2026 | 160.20K | $506.23K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ESPR
- BlackRock Inc 22.13M sh · $69.92M · Q2 2026
- Vanguard Group 14.95M sh · $55.30M · Q4 2025
- Goldman Sachs Group 10.38M sh · $32.80M · Q2 2026
- Two Sigma Investments 7.13M sh · $22.52M · Q2 2026
- Geode Capital Management 6.63M sh · $20.96M · Q2 2026
- Balyasny Asset Management 4.65M sh · $14.71M · Q2 2026
- Fidelity Management & Research (FMR) 4.61M sh · $14.58M · Q2 2026
- UBS Group AG 3.84M sh · $12.12M · Q2 2026
- Northern Trust Corp 2.32M sh · $7.34M · Q2 2026
- Millennium Management 2.23M sh · $7.03M · Q2 2026
- Fidelity International (FIL) 2.11M sh · $6.66M · Q2 2026
- JPMorgan Chase & Co 1.40M sh · $4.40M · Q2 2026